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Genetic Features Differentiating Bovine, Food, and Human Isolates of
Shiga Toxin-Producing Escherichia coli O157 in The Netherlands
Eelco Franz,a Angela H. A. M. van Hoek,a Fimme J. van der Wal,b Albert de Boer,b Ans Zwartkruis-Nahuis,d Kim van der Zwaluw,c
Henk J. M. Aarts,a and Annet E. Heuvelinkd*
National Institute for Public Health and the Environment (RIVM), Centre for Infectious Disease Control, Laboratory for Zoonoses and Environmental Microbiology,
Bilthoven, The Netherlandsa; Central Veterinary Institute of Wageningen University & Research Centre, Lelystad, The Netherlandsb; National Institute for Public Health and
the Environment, Centre for Infectious Disease Control, Laboratory for Infectious Diseases and Perinatal Screening, Bilthoven, The Netherlandsc; and Food and Consumer
Product Safety Authority, Zutphen, The Netherlandsd
The frequency of Escherichia coliO157 genotypes among bovine, food, and human clinical isolates from The Netherlands was
studied. Genotyping included the lineage-specific polymorphism assay (LSPA6), the Shiga-toxin-encoding bacteriophage inser-
tion site assay (SBI), and PCR detection and/or subtyping of virulence factors andmarkers [stx1, stx2a/stx2c, q21/Q933,
tir(A255T), and rhsA(C3468G)]. LSPA6 lineage II dominated among bovine isolates (63%), followed by lineage I/II (35.6%) and
lineage I (1.4%). In contrast, the majority of the human isolates were typed as lineage I/II (77.6%), followed by lineage I (14.1%)
and lineage II (8.2%). Multivariate analysis revealed that the tir(A255T) SNP and the stx2a/stx2c gene variants were the genetic
features most differentiating human from bovine isolates. Bovine and food isolates were dominated by stx2c (86.4% and 65.5%,
respectively). Among human isolates, the frequency of stx2c was 36.5%, while the frequencies of stx2a and stx2a plus stx2c were
41.2% and 22.4%, respectively. Bovine isolates showed equal distribution of tir(255A) (54.8%) and tir(255T) (45.2%), while hu-
man isolates were dominated by the tir(255T) genotype (92.9%). LSPA6 lineage I isolates were all genotype stx2c and tir(255T),
while LSPA6 lineage II was dominated by tir(255A) (86.4%) and stx2c (90.9%). LSPA6 lineage I/II isolates were all genotype
tir(255T) but showedmore variation in stx2 types. The results support the hypothesis that in The Netherlands, the genotypes
primarily associated with human disease form aminor subpopulation in the bovine reservoir. Comparison with published data
revealed that the distribution of LSPA6 lineages among bovine and human clinical isolates differs considerably between The
Netherlands and North America.
Shiga toxin-producing Escherichia coli (STEC) O157 is consid-ered a serious pathogen due to its low infectious dose, the
severe clinical symptoms (especially among children), and the po-
tential for food- andwaterborne outbreaks (7, 22, 35). STECO157
can be transmitted to humans by direct contact with the ruminant
reservoir or indirectly via ingestion of contaminated food orwater
(33). STEC O157 has several virulence genes that play a crucial
role in the development of clinical symptoms. These include the
Shiga toxin genes 1 and 2 (stx1 and stx2), several genes located on
the chromosomal locus of enterocyte effacement (LEE), which
codes for a specialized epithelium attachment system responsible
for the characteristic attaching and effacing (A/E) phenotype, and
(putative) virulence factors encoded on various genomic patho-
genicity islands (20, 25).
In The Netherlands, the prevalences of STEC O157 at the herd
level are on average 8% for dairy herds and 13% for veal herds (2),
with seasonal peaks from 30% to 70%during the summermonths
(12, 19). The notification rates of STECO157 disease cases in The
Netherlands (including outbreaks) for 2007, 2008, and 2009 were
0.50, 0.27, and 0.34 cases per 100,000 inhabitants per year, respec-
tively (14). It can be considered paradoxical that the number of
human STEC O157 infections is rather low for a pathogen with a
low infectious dose when herd-level prevalence is relatively high.
This could, at least partly, be explained if only a subset of STEC
O157 isolates present in the bovine reservoir are characterized by
unique transmissibility and/or virulence characteristics (6).
To assess the public health risk associatedwith STECO157, it is
important to understand the genotypic diversity among STEC
O157 isolates. Distinguishing STECO157 isolates that constitute a
high risk to human health from isolates that have a lower associ-
ation with clinical symptoms is an important aspect of risk-based
monitoring and surveillance. Recently, several PCR typing assays
have been reported discriminating between bovine and human
clinical STEC O157 isolates. The lineage-specific polymorphism
assay LSPA6 uses six loci derived from octamer-based genome
scanning to classify STEC O157 isolates into three major lineages
(23, 43), which have previously been shown to display a nonran-
dom distribution among human and bovine isolates in North
America (38, 43, 45) and Japan (26). A typing assay based on Shiga
toxin-encoding bacteriophage insertion sites clustered STEC
O157 isolates with nonrandom distribution among bovine and
human clinical isolates (3, 37). Additional genetic markers found
to occur at different relative frequencies among clinical and bo-
vine isolates include variants of the stx2-Q antiterminator junction
alleles (Q933 and q21) (27), the single nucleotide polymorphism
(SNP) in the tir gene [tir(255T) and tir(255A)] (6), and stx2 gene
variants (4, 9, 13). Manning et al. (34) developed a subtyping
scheme based on 32 SNPs which separated STEC O157 isolates
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into 9 distinct evolutionary clades, with clade 8 isolates being
more virulent than other isolates.
Themain objective of the present studywas to genetically char-
acterize and compare bovine, food, and human clinical STEC
O157 isolates from The Netherlands using various genotyping
methods and multivariate statistics. The goal was to determine
whether different genotypes occur at different frequencies among
isolates from these different sources and to identify the genetic
features most differentiating the isolates from these sources. A set
of 73 bovine, 29 food, and 85 human clinical isolates were used.
The most distinctive genetic features that separated bovine and
human clinical isolates were identified using multivariate statisti-
cal analyses. The results showed clear nonrandom distributions of
genotypes among bovine, food, and human clinical isolates. In
addition, comparisonwith published data revealed significant dif-
ferences in the distribution of LSPA6 lineages among bovine and
human isolates between The Netherlands versus North America
and Japan.
MATERIALS AND METHODS
Isolates and growth conditions. A set of 187 STEC O157 isolates (73
bovine, 29 food, and 85 human clinical isolates) was obtained from the
collection of the Food andConsumer Product Safety Authority (Zutphen,
The Netherlands) and the National Institute for Public Health and The
Environment (Bilthoven, The Netherlands). All isolates possessed the
genes encoding Shiga toxin 2 (stx2), intimin (eae), and hemolysin (hlyA).
The bovine isolates were isolated from 2002 to 2009 during national sur-
veys and were maintained in cryovials (Microbak, Pro-Lab). The clinical
human isolates were strains isolated from patients with STEC symptoms
and sent in by hospitals for confirmation in the period 1999 to 2010. The
food strains (23 meat isolates and 6 leafy green isolates) were isolated
during national surveys by the Food and Consumer Product Safety Au-
thority in the Netherlands. All clinical human isolates were maintained at
room temperature in Mueller-Hinton agar. Isolates were propagated on
blood agar or nutrient agar (Oxoid), and DNA was extracted using the
Chelex-100 (Bio-Rad, Hercules, CA) resin-based technique. One colony
of each isolate was transferred into 300 l 10% Chelex-100 solution,
which was subsequently heated for 5 min at 56°C to resuspend the cells.
The tubes were briefly cooled at room temperature and mixed for 15 s
before heating for 15 min at 98 to 99°C for lysis of the bacteria. After
cooling at room temperature, the lysates were centrifuged for 5 min at
13,000 rpm, and up to 200l of the supernatant was transferred to a clean
tube and stored at20°C.
Genetic profiling. All isolates were characterized by two alternative
molecular genotyping assays (the lineage-specific polymorphism assay
and the Shiga toxin-encoding bacteriophage insertion site assay) and four
additional genetic markers: stx2a/stx2c, q21/Q933, tir(A255T), and clade 8
rhsAb(C3468G). Table 1 provides an overview of the primers and probes
used. STECO157 EDL 933 (ATCC 43895) was used as a control strain for
all assays.
LSPA6 was performed in essence as described previously (43), using
the LSPA6 primer sequences listed in Table 1. Amplicons were generated
in two multiplex PCRs: one PCR mixture contained the folD-sfmA, rtcB,
and yhcG primers, and the other PCR mixture contained the arp-iclR,
rbsB, and Z5935 primers. After amplification (GeneAmp PCR system
9700 in 9600 mode; Applied Biosystems), the products were separated on
a capillary sequencer (3130 genetic analyzer; Applied Biosystems) in the
presence of an internal marker (GeneScan 600 LIZ size standard; Applied
Biosystems). Raw data were analyzed using BioNumerics 6.1 (Applied
Maths) to determine fragment sizes. Arranged in the order folD-sfmA,
rbsB, Z5935, rtcB, arp-iclR, and yhcG, each allele was assigned a number as
described previously (43). Isolates showing the LSPA6 genotype 111111
were classified as LSPA6 lineage I (LSPA6 LI), while those with LSPA6
genotype 211111 were classified as LSPA6 lineage I/II (LSPA6 LI/II).
Unique alleles (aberrant amplicon size) were assigned new numbers. All
deviations from the genotypes 111111 and 211111 were classified as
LSPA6 lineage II (LSPA6 LII) (42, 43, 45).
The Shiga toxin-encoding bacteriophage insertion site (SBI) assay
consists of six PCRs that amplify the Shiga toxin genes and their genomic
insertion site junctions of the Shiga toxin-encoding bacteriophages of
STEC O157 (3, 37). The presence of intact or occupied chromosomal
insertion site regions (yehV andwrbA) was determined for all isolates. The
PCR results of the amplification of the bacteriophage-yehV right and left
junctions (yehV-R and yehV-L, respectively) and the bacteriophage-wrbA
left and right junctions (wrbA-R and wrbA-L, respectively) were binary
interpreted as the sites being occupied (amplification) or intact (no am-
plification). Based on the yehV-R, yehV-L, wrbA-R, and wrbA-L PCR re-
sults in combination with the presence of stx1 and/or stx2, different SBI
genotypes were assigned.
The q21/Q933 assay targets two different allelic variations of the anti-
terminator geneQ upstream of the prophage stx2 region (27). AlleleQ933
is responsible for a strong antiterminator activity resulting in relatively
high expression levels of stx2, while allele q21 represents a weak antitermi-
nator activity resulting in lower stx2 expression levels (41). The assay was
conducted as described by Lejeune et al. (27).
The tir(A255T) assay targets anA255¡Tnucleotide polymorphism in
the gene coding for the translocated intimin receptor and was found to
provide a clear discrimination between human and bovine isolates (6).
The assay was conducted as described by Bono et al. (5) on a LightCycler
480 real-time PCR system (Roche Diagnostics Nederland B.V., Almere,
The Netherlands) with different dyes attached to the probes (Table 1).
The clade 8_rhsA assay targets one of the single nucleotide polymor-
phisms (SNPs) possible in the rhsA gene (SNP position 3468) (29). A PCR
fragment with a length of 635 bp was generated with the rhsA primers
indicated in Table 1. The 50-l PCR mixture contained 1 PCR buffer
(Invitrogen BV, Breda, TheNetherlands), 2.5mMMgCl2, 0.2mMdeoxy-
nucleoside triphosphates (dNTPs), 0.2 M each primer, 1 U Taq DNA
polymerase (Invitrogen BV, Breda, TheNetherlands), and 2l DNA tem-
plate (approximately 20 ng). PCR restriction fragment analysis was per-
formed on 5 l of the rhsA PCR product using 10 U of either HaeII or
Sau96I (New England BioLabs, Ipswich,MA) and the recommended buf-
fer at 37°C for 2 h. The restriction fragments were separated in a 2%
agarose gel. The size of DNA fragments was estimated in comparison to a
marker: a 100-bp DNA ladder (New England BioLabs, Ipswich, MA).
With clade 8 isolates [rhsA(3468C)], 2 fragments will be generated after
digestion with HaeII (lengths, 525 and 110 bp), whereas Sau96I will result
in 3 bands on the gel (lengths, 296, 273, and 66 bp). Non-clade 8 isolates
[rhsA(3468G)]will produce the following results:HaeII, 269, 256, and 110
bp; and Sau96I, 339 and 296 bp.
The stx2a/stx2c assay is based on the amplification of a part of the
upstream region of the stx2 operon and the A and B subunit genes, fol-
lowed by restriction fragment analysis. The PCR fragment with a length of
1,566 bp with stx2a and 1,560 bp with stx2c was generated in a 50-l PCR
mixture containing 1 PCR buffer (Invitrogen BV, Breda, The Nether-
lands), 2 mM MgCl2, 0.2 mM dNTPs, 0.2 M each stx2/stx2c primers
(Table 1), 1 U Taq DNA polymerase (Invitrogen BV, Breda, The Nether-
lands), and 2 l DNA template (approximately 20 ng). PCR-restriction
fragment analysis was performed on 5 l of the generated PCR product
using 10 U of either HincII or ScaI (New England BioLabs, Ipswich, MA)
and the recommended buffer at 37°C for 2 h. The restriction fragments
were separated in a 1.5% agarose gel. The size of the DNA fragments was
estimated in comparison to a marker: a 100-bp DNA ladder (New Eng-
land BioLabs, Ipswich, MA). The following fragments were generated
with HincII: stx2a, 1,163, 262, 79, and 62 bp; and stx2c, 1,157, 324, and 79
bp. The following fragments were generatedwith ScaI: stx2a, 1,566 bp; and
stx2c, 1,432 and 128 bp.
Data analysis.Differences in frequencies of genetic markers (denoted
in binary values 0 and 1) between isolates from different sources (bovine,
food, and human) were statistically evaluated using the chi-square test
Genotyping STEC O157 from Different Isolation Sources
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(IBM SPSS Statistics, version 19). In order to identify the genetic features
most differentiating between isolates of different origins, multinomial
logistic regression analysis was performed (IBM SPSS Statistics, version
19) with the data on the human clinical isolates as the reference category.
Principal component analysis (PCA) was performed, and biplots (show-
ing observation and variables) were created using SAS Stat studio 3.1 (SAS
Institute, Inc., Cary, NC).
RESULTS
Lineage specific polymorphism assay. In total, 9.1% of STEC
O157 isolates from The Netherlands were typed as LSPA6 lineage
I, 55.1% as lineage I/II, and 35.8% as lineage II (Table 2). The
distribution of the LSPA6 lineages was significantly associated
with the isolation source (2  73.3, df  3, P  0.001). LSPA6
lineage II dominated among bovine isolates (63.0%), followed by
lineage I/II (35.6%) and lineage I (1.4%). The majority of the
human isolates were typed as lineage I/II (77.6%), followed by
lineage I (14.1%) and lineage II (8.2%). The distribution of LSPA6
lineages among food isolates was intermediate between the com-
positions of bovine and human isolates (lineage II, 48.3%; lineage
I/II, 37.9%; lineage I, 13.8%). The diversity of LSPA6 lineages was
higher among bovine isolates than food and human isolates, with
totals of 17 different LSPA6 genotypes among bovine isolates, 8
different genotypes among the food isolates, and 5 genotypes
among human isolates (Table 2).
Shiga toxin-encoding SBI assay. Characterization of the bac-
teriophage insertion site genotypes revealed that genotypes 1, 3, 5,
and 6 accounted for 93% of the bovine isolates and food isolates
and for 72% of the clinical isolates in The Netherlands (Table 3).
The distribution of the SBI genotypes was associated with the iso-
lation source (2  54.6, df  8, P  0.001). The Dutch bovine
TABLE 1 Oligonucleotides used in this study
Assay Target Type Sequence (5=¡3=)a Reference
Clade 8_rhsA rhsA Primer CCACAATACAGAACGACAGA This study
Primer ACCTTGCGGATCTACATTTA
LSPA6 folD-sfmA Primer NED-TACGTAGGTCGAAGGG 43
Primer CCAGATTTACAACGCC
Z5935 Primer FAMc-GTGTTCCCGGTATTTG 43
Primer CTCACTGGCGTAACCT
yhcG Primer VIC-CTCTGCAAAAAACTTACGCC 43
Primer CAGGTGGTTGATCAGCG
rbsB Primer VIC-AGTTTAATGTTCTTGCCAGCC 43
Primer ATTCACCGCTTTTTCGCC
rtcB Primer FAM-GCGCCAGATCGATAAAGTAAG 43
Primer GCCGTTGTAAACGTGATAAAG
arp-iclR Primer NED-GCTCAATCTCATAATGCAGCC 43
Primer CACGTATTACCGATGACCG
q21/Q933 q21-stx2a Primer GAAATCCTCAATGCCTCGTTG 27
Primer CCGAAGAAAAACCCAGTAACAG
Q933-stx2a Primer CGGAGGGGATTGTTGAAGGC 27
Primer CCGAAGAAAAACCCAGTAACAG
SBI stx1 Primer CGCTTTGCTGATTTTTCACA 37
Primer GTAACATCGCTCTTGCCACA
stx2 Primer GTTCCGGAATGCAAATCAGT 37
Primer CGGCGTCATCGTATACACAG
yehV-LJb Primer CACCGGAAGGACAATTCATC 37
Primer CCGACCTTTGTACGGATGTAA
yehV-RJb Primer AACAGATGTGTGGTGAGTGTCTG 37
Primer CGAATCGCTACGGAATAGAGA
wrbA-LJb Primer AAGTGGCGTTGCTTTGTGAT 37
Primer AGGAAGGTACGCATTTGACC
wrbA-RJb Primer GATGCACAATAGGCACTACGC 37
Primer ATCGTTCGCAAGAATCACAA
stx2a/stx2c stx2a, stx2c Primer GTGGTGAGAGCGAGCGAC This study
Primer GTCATTATTAAACTGCACTTCAG
tir(A255T) tir Primer TGGCGGCGTCTGAGATAAC 5
Primer GAGTATCGAGCGGACCATGATC
tir(A255) Probe Cy5-ACTGAATGATGGATTTG-BHQ2
tir(T255) Probe FAM-CTGAATGAAGGATTTG-BHQ1
a The reverse primer has homology with stx2a as well as stx2c.
b LJ is left junction, and RJ is right junction.
c FAM, 6-carboxyfluorescein.
Franz et al.
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STEC O157 isolates were dominated by SBI genotypes 5 (40.8%)
and 1 (32.9%), while the clinical isolates were dominated by ge-
notype 1 (49.7%). The food isolates showed a distribution of SBI
genotypes intermediate between those observed for bovine and
human clinical isolates. SBI genotypes 1 and 21 were found in a
significantly higher frequency among clinical isolates compared to
bovine isolates (2 81, df 1, P 0.001, and 2 14, df 1,
P 0.001, respectively), while genotype 5 was found in a signifi-
cantly higher frequency among bovine isolates (2  45, df  1,
P  0.001). In relation to the bovine and human isolates, geno-
types 1 and 5 were found at intermediate frequencies among the
food isolates (37.9% and 20.7%, respectively).
q21/Q933 and stx2a/stx2c assays. The distributions of the Q
allele variant (q21 and Q933) and the stx2 variant (stx2a and stx2c)
were significantly associated with the isolation source (2 55.9,
df 4, P 0.001, and 2 55.7, df 3, P 0.001, respectively).
Bovine and food isolates primarily harbored the stx2c gene variant
(86.4% and 65.5%, respectively) (Table 4). The distribution of
stx2a/stx2c genotypes among human isolates was less skewed, with
frequencies of 36.5% for stx2c, 22.4% for stx2a, and 22.4% for stx2a
plus stx2c. The occurrence of the Q gene variants was correlated
with the stx2 subtype (stx2a and stx2c), withQ933mostly associated
with stx2a and q21 with stx2c. Therefore, the distribution of the Q
gene variants highly resembled the distribution of the stx2 variants
(Table 4).
tir(A255T) polymorphism assay. The distribution of the
tir(255A) and tir(255T) alleles was associated with the isolation
source (2  49.0, df  2, P  0.001). While tir(255A) and
tir(255T) were approximately equally distributed among bovine
isolates (respectively, 54.8% and 45.2%), the tir(255T) allele was
dominant among food isolates (62.1%) and was overrepresented
among human clinical isolates (92.9%) (Table 4).
Clade 8_rhsA assay. The distribution of STEC O157 clade 8
isolates [rhsA(3468C) variant] was not associated with isolation
source (2 0.76, df 2, P 0.686). The frequencies of clade 8
isolates were approximately equal among the bovine (41.0%),
food (44.8%), and human clinical isolates (38.8%). Clade 8 iso-
TABLE 2 Distribution of LSPA6 lineages among STEC O157 strains
from bovine, food, and human clinical cases from The Netherlands
Genotypea Lineage
No. (%) of strains with lineage shown:
Total
Bovine
(n 73)
Food
(n 29)
Clinical
(n 85)
111111 I 17 (9.1) 1 (1.4) 4 (13.8) 12 (14.1)
211111 I/II 103 (55.1) 26 (35.6) 11 (37.9) 66 (77.6)
211112 II 7 (3.7) 5 (6.8) 1 (3.4) 1 (1.2)
212221 II 20 (10.7) 11 (15.1) 8 (27.6) 1 (1.2)
212222 II 20 (10.7) 13 (17.8) 2 (6.9) 5 (5.9)
212231b II 4 (2.1) 4 (5.5) 0 0
212232b II 3 (1.6) 2 (2.7) 1 (3.4) 0
212321b II 1 (0.5) 1 (1.4) 0 0
212322b II 2 (1.1) 2 (2.7) 0 0
213111b II 1 (0.5) 1 (1.4) 0 0
214222b II 2 (1.1) 2 (2.7) 0 0
215232b II 1 (0.5) 1 (1.4) 0 0
216222b II 1 (0.5) 1 (1.4) 0 0
222242b II 2 (1.1) 2 (2.7) 0 0
224242b II 1 (0.5) 1 (1.4) 0 0
212111b II 1 (0.5) 0 1 (3.4) 0
215222b II 1 (0.5) 0 1 (3.4) 0
a The character string in the genotype indicates the allele number at the folD-sfmA,
rbsB, Z5935, rtcB, arp-iclR, and yhcG loci.
b Genotypes based on newly observed fragments.
TABLE 3 Distribution of Shiga toxin-encoding SBI genotypes among bovine, food, and human clinical STEC O157 isolates from The Netherlands
Genotypea
Genotyping data No. (%) of isolates
stxb yehVc wrbAd Bovine (n 73) Food (n 29) Human (n 85)
1 stx2 Occupied Intact 24 (32.9) 11 (37.9) 42 (49.7)
3 stx1 stx2 Occupied Occupied 1 (1.3) 3 (10.3) 5 (5.9)
5 stx2 Variant-R Intact 30 (40.8) 6 (20.7) 3 (3.5)
6 stx1 stx2 Variant-R Intact 13 (18.4) 6 (20.7) 12 (14.2)
11 stx2 Intact Intact 1 (1.3) 1 (3.5) 1 (1.2)
16 stx1 stx2 Occupied Intact 2 (2.6) 1 (3.5) 6 (7.1)
21 stx2 Occupied Variant-L 2 (2.6) 1 (3.5) 9 (10.1)
NTe 0 (0) 0 7 (8.2)
a Stx-encoding bacteriophage insertion site genotypes based on patterns of stx genes and Stx-encoding bacteriophage insertion sites.
b PCR detection of stx1 and stx2 genes.
c “Occupied” indicates detection of the yehV-Stx1-encoding bacteriophage left and right junctions. “Intact” indicates the detection of neither junction. “Variant-R” indicates that
the left junction was detected (occupied) but the right junction was not detected (intact).
d “Occupied” indicates bilateral detection of the wrbA-Stx2-encoding bacteriophage junctions. “Intact” indicates the detection of neither junction. Variant-L indicates that the left
junction was not detected (intact) but the right junction was detected (occupied).
e NT, nontypeable.
TABLE 4 Distribution of virulence factors among STEC O157 strains of
bovine, food, and human clinical origin from The Netherlands
Genotype
No. (%) of strains with virulence factor
Total
Bovine
(n 73)
Food
(n 29)
Human
(n 85)
stx2a 50 (26.7) 5 (6.8) 8 (27.6) 35 (41.2)
stx2c 113 (60.5) 63 (86.4) 19 (65.5) 31 (36.5)
stx2a stx2c 24 (12.8) 5 (6.8) 2 (6.9) 19 (22.4)
q21 113 (60.5) 62 (84.9) 18 (62.1) 33 (38.8)
Q933 44 (23.5) 7 (9.6) 8 (27.6) 29 (34.1)
q21 Q933 23 (12.3) 1 (1.4) 2 (6.9) 20 (23.5)
Neither q21 nor Q933 7 (3.7) 3 (4.1) 1 (3.4) 3 (3.5)
tir(255A) 57 (30.5) 40 (54.8) 11 (37.9) 6 (7.1)
tir(255T) 130 (69.5) 33 (45.2) 18 (62.1) 79 (92.9)
rhsA(3468C) 76 (40.6) 30 (41.1) 13 (44.8) 33 (38.8)
rhsA(3468G) 111 (59.4) 43 (58.9) 16 (55.2) 52 (61.2)
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lates were not specifically associated with one of the LSPA6 lin-
eages.
Multivariate analyses of population structure. Multivariate
statistical techniques were applied in order to gain insight into
relationships between the genetic variables investigated and to
elucidate the most distinctive genetic features differentiating bo-
vine, food, and human clinical STEC O157 isolates. Principal
component analysis was used as an ordination technique and re-
vealed the discrimination of bovine and human isolates based on
the studied geneticmarkers (Fig. 1). Althoughmost of themarkers
contributed considerably to the observed clustering, the allelic
variants of the tir gene [Tir(255A) and Tir(255T)] and the stx2
subtypes (stx2a/stx2c) explained most of the observed clustering.
The ordination plot of the PCA showed that the presence of the tir
variants was correlated to the values of the LSPA6markers Z5935,
rtcB, arp-iclR, and yhcG. Indeed, all LSPA6 lineage I and I/II iso-
lates harbored the tir(255T) variant, and 88% of the lineage II
isolates contained tir(255A). The presence of stx2a and/or stx2c was
highly correlated to the Q933 and q21 gene variants: i.e., 96% of
the isolates carrying stx2c were positive for the q21 variant, and
95% of the isolates carrying the stx2a variant were positive for the
Q933 allelic variant. The presence/absence of the stx1 gene and the
clade 8 marker rhsA(3468C) were negatively correlated with each
other, and both markers were uncorrelated to all other markers
tested.
Multinomial logistic regression analysis was conducted to sta-
tistically identify the genetic features differentiating bovine, clin-
ical and food isolates. Univariate analysis revealed significant
associations (P 0.05) of stx2a/stx2c, q21/Q933, tir(A255T), folD-
sfmA, Z5935, yhcG, rtcB, yehV-RJ, and wrbA-RJ with the isolation
source (Table 5).However, with themultivariate analysis, only the
stx2a/stx2c and tir(A255T) variants were significantly (P  0.001
and P 0.0001, respectively) associated with the isolation source
and were subsequently identified as the genetic features most dif-
ferentiating between STEC O157 isolates from the bovine reser-
voir, food, and humans (Table 5).
The distribution of genotypes defined by the different combi-
nations of the tir(A255T) SNP and the stx2a/stx2c gene variations
markedly differed between the isolation sources and between the
LSPA6 genotypes (Table 6). The frequency of tir(255A) plus stx2c
was clearly lower among human isolates relative to bovine isolates
(respectively, 4.7% and 53.4%, an 11-fold difference). In contrast,
genotype tir(255T) stx2astx2c was clearly more present among hu-
man isolates than among bovine ones (respectively, 22.4% and
FIG1 Ordination plot showing the results of the PCA for all geneticmarkers tested on STECO157 isolates frombovine (green squares), food (blue squares), and
human clinical cases (pink squares) from The Netherlands. Isolates clustering together have similar genetic compositions. The strength of the contribution of a
specific genetic feature to the explained variation is indicated by the projected length of the line on the horizontal and vertical axes. Dim1 andDim2 represent the
first two dimensions of the PCA.
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1.4%, 16-fold difference). Also genotype tir(255T) stx2a was
higher in numbers among human isolates (37.6%) than among
bovine isolates (11.0%) (3-fold difference). The frequencies of
genotypes tir(255A) stx2a stx2c and tir(255T) stx2c were more or
less equal between the different isolation sources (Table 6).
LSPA6 lineage I isolates were all genotype tir(255T) stx2c, while
LSPA6 lineage II was dominated by the tir(255A) stx2c genotype
(80.3%) (Table 6). Although LSPA6 lineage I/II isolates were all
tir(255T), they showed more variation in combination with the
stx2a/stx2c gene variants (Table 6).
No differences were found in the frequencies of genotypes de-
fined by the different combinations of the tir(A255T) SNP and the
stx2a/stx2c gene variations between isolates from persons that were
hospitalized and those from persons who were not. The same ap-
plied for hemolytic-uremic syndrome (HUS) versus non-HUS
patients. The seven HUS isolates were characterized as follows:
LSPA6 I/II, stx2a stx2c tir(255T) (n 2); LSPA6 I/II, stx2a tir(255T)
(n  3); LSPA6 I/II, stx2c tir(255T) (n  1); and LSPA6 II, stx2c
tir(255A) (n 1). Among the food isolates, six were isolated from
fresh produce. Five of these isolates were characterized by LSPA6
LII, tir(255A), and stx2c, while one strain was characterized by
LSPA6 LI/II, tir(255T), and stx2c.
DISCUSSION
In this study, major differences were revealed in the frequencies of
STEC O157 genotypes among isolates from the bovine reservoir,
food, and humans using LSPA6 and SBI genotyping methods and
PCR typing of virulence factors. The results demonstrated that
STEC O157 genotypes and genetic polymorphisms occurring at
high frequency among human clinical isolates [LSPA6 lineage I/II,
stx2a, Q933, and tir(255T)] occurred at relatively low numbers
among bovine isolates. Similarly, genotypes occurring at high fre-
quency among bovine isolates [LSPA6 lineage II, tir(255A), stx2c,
q21, and SBI genotype 5] were less prevalent among human clin-
ical isolates. These observations support the hypothesis that only a
fraction of STEC O157 strains in the bovine reservoir are associ-
ated with causing disease in humans. Food isolates mostly showed
genotype andmarker frequencies intermediate between those ob-
served among bovine and human clinical isolates, indicating a
possible role for food as a selection agent for potentially human-
associated genotypes. Multivariate statistical analysis showed that
the most distinctive genetic features differentiating human from
bovine isolates were tir(255T) and stx2a. Genotypes defined by the
combination of these two markers were strongly correlated to the
LSPA6 lineage and nonrandomly distributed among bovine and
human isolates.
The results clearly showed different STEC O157 population
TABLE 5 Result of univariate and multivariate multinomial regression analysis of gene presence among bovine, food, and clinical human STEC
O157 isolates from The Netherlandsd
Variable
Univariable analysisa Multivariable analysisa,b
Bovine Food Bovine Food
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
stx1 0.68 (0.33–1.40) 0.294 1.34 (0.54–3.29) 0.526
stx2a 0.13 (0.06–0.27) 0.0001 0.33 (0.14–0.81) 0.015 0.25 (0.11–0.54) 0.001 0.54 (0.21–1.41) 0.208
stx2c 5.08 (2.30–11.24) 0.0001 2.02 (0.81–5.08) 0.133
q21 3.74 (1.73–8.13) 0.001 1.41 (0.57–3.47) 0.454
Q933 0.13 (0.06–0.28) 0.0001 0.41 (0.17–0.98) 0.044
tir(255A) 14.71 (5.68–37.03) 0.0001 8.06 (2.63–24.39) 0.0001
tir(255T) 0.07 (0.03–0.18) 0.0001 0.12 (0.04–0.38) 0.0001 0.12 (0.04–0.31) 0.0001 0.16 (0.05–0.53) 0.003
rhsA(3468C) 1.21 (0.65–2.27) 0.554 1.28 (0.55–3.00) 0.570
rhsA(3468G) 0.83 (0.44–1.55) 0.554 0.78 (0.33–1.83) 0.570
folD-sfmA 12.35 (1.56–97.00) 0.017 1.03 (0.30–3.47) 0.003
Z5935 12.73 (5.02–32.26) 0.0001 9.51 (3.50–25.83) 0.0001
yhcG 0.123 (0.09–0.32) 0.0001 0.37 (0.10–1.3) 0.0001
rtcB 14.12 (3.53–6.06) 0.0001 7.43 (2.49–22.18) 0.0001
rbsB NAc NA
yehV-LJ 0.30 (0.02–1.05). 0.056 0.37 (0.10–1.3) 0.120
yehV-RJ 3.68 (1.91–7.09) 0.002 1.69 (0.71–4.06) 0.237
wrbA-LJ 4.69 (0.53–41.06) 0.163 0.39 (0.01–1.57) 0.185
wrbA-RJ 8.50 (2.43–29.73) 0.001 1.34 (0.48–3.72) 0.567
a The odds ratios (ORs) indicate whether a gene or allelic variant is more (1) or less (1) likely to be associated with the bovine or food isolates compared to the human isolates.
(The human isolates serve as the reference in the regression analysis.) 95% CI, 95% confidence interval. The P values shown represent the P values of the ORs.
b Model fit, P 0.0001; likelihood ratio tests, stx2a, chi-square 13.74, P 0.002; tir(T255), chi-square 23.39, P 0.0001.
c NA, not available. The OR could not be calculated because all human and food isolates showed the same allelic type (type 1) in the rbsB locus.
d Significant values are indicated in boldface.
TABLE 6 Frequencies of STEC O157 tir(255A)/tir(255T) and stx2a/stx2c
genotypes based on isolation source and LSPA6 lineage
Genotype
Frequency (%) of genotype bya:
Isolation source Lineage
Bovine Food Human
LSPA6
I
LSPA6
I/II
LSPA6
II
tir(255A) stx2a 0 0 0 0 0 0
tir(255A) stx2c 53.4 37.9 4.7 0 0 80.3
tir(255A) stx2a stx2c 2.7 0 2.4 0 0 6.1
tir(255T) stx2a 11.0 31.0 37.6 100 31.7 3.0
tir(255T) stx2c 31.5 24.1 32.9 0 51.0 10.6
tir(255T) stx2a stx2c 1.4 6.9 22.4 0 17.3 0
a Shown are the percentages of the total number of isolates in each group.
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structures among bovine, food, and human clinical isolates based
on LSPA6 genotype distribution. While the LSPA6 LII genotypes
dominated among bovine isolates of STEC O157, they formed a
minority among human isolates. In turn, human isolates were
dominated by LSPA6 LI/II (211111). LSPA6 LI (111111) was
found to be a relatively rare genotype in The Netherlands (1.4%,
13.8%, and 14.1% among bovine, food, and human clinical iso-
lates, respectively). Data from North America, where the STEC
O157 disease incidence is higher than that in the Netherlands,
showed different LSPA6 genotypic distributions among bovine
and human clinical isolates. Originally, Kim et al. (23) described
the existence of two distinct lineages of STEC O157 from the Un-
tied States: lineage I was composed mostly of clinical isolates (36/
44), and lineage II consistedmostly of cattle isolates (25/32).How-
ever, Yang et al. (43) reported the dominance of LSPA6 LI among
both U.S. cattle and human clinical isolates. Similarly, in Canada
the majority of cattle and human clinical isolates were typed as
LSPA6 LI (38, 45). In Japan, LSPA6 LI was dominant among hu-
man isolates (69%), but all three LSPA6 lineages were consider-
ably represented among cattle isolates (26). The present study
showed that the occurrence of LSPA6 genotypes in The Nether-
lands is clearly different from those in North America and Japan.
The most striking differences are the low frequency of LSPA6 LI
isolates and the high frequency of LSPA6 LI/II isolates among
human clinical isolates. Earlier postulated statements on the in-
creased capability of LSPA6 LI isolates to cause disease in humans
and the rapid spread of this lineage into a previously unoccupied
ecological niche (30) do not seem to be supported by the Dutch
LSPA6 genotypic distribution.
In contrast to earlier published results from the United States
on the distribution of SBI genotypes among bovine and human
isolates (3), the results of the present study do not show a higher
diversity among STEC O157 isolates from the bovine reservoir
compared to human isolates. Seven different (untypeable isolates
excluded) SBI genotypes were observed among bovine isolates as
well as among food and human clinical isolates. Besser et al. (3)
observed four different SBI genotypes among human isolates
from theUnited States, but 93% of all isolates were represented by
genotypes 1 (30%) and 3 (62%), which together also comprised
nearly 60% of the bovine isolates. In sharp contrast, in The Neth-
erlands, SBI genotype 3 seemed of minor importance. Similar to
the United States, in The Netherlands, SBI genotype 1 could be
identified as a risk genotype since it comprised 50% of the human
clinical isolates. Although dominant among Dutch bovine iso-
lates, SBI genotype 5 was found to be of little clinical importance.
In contrast, the clinical association of SBI genotype 1 is associated
with increased expression of virulence (LEE and pO157) genes
compared to the bovine-associated genotype 5 (40). In turn, bo-
vine genotype 5 is associatedwith increased acid survival (40). The
capacity to withstand extreme acidity is critical for STEC O157
isolates in order to successfully colonize cattle. In addition, in-
creased expression of the central activator of the glutamate decar-
boxylase acid resistance system negatively regulates expression of
LEE (39).
Clade 8 isolates of STEC O157 were suggested to be more vir-
ulent than isolates from other clades (34). Recent studies demon-
strated that U.S. clade 8 isolates belonged primarily to LSPA6 ge-
notype 211111 (LI/II) (24, 29). However, in the present study, no
specific association of clade 8 isolates with a particular LSPA6
lineage inTheNetherlandswas observed. In Sweden, clade 8 STEC
O157 isolates were overrepresented among isolates from cattle
farms associated with human cases compared with STEC O157
isolates isolated in prevalence studies (10). In The Netherlands,
clade 8 isolates were not more prevalent among human clinical
isolates compared to bovine isolates and are therefore not suitable
as marker for identifying isolates with increased risk of causing
clinical infections.
The Q933 variant of the antiterminator gene Q, located up-
stream of the stx2 gene, resulting in relatively high expression of
the stx2 gene, was initially reported as a useful marker for (poten-
tial) human risk among bovine isolates since only 44% of the
bovine isolates and 83% of the human clinical isolates were posi-
tive for Q933 (27). In The Netherlands, the frequency of Q933
increased from 10% among bovine isolates to 34% among human
clinical isolates. In addition, the frequency of isolates carrying
both gene variants (q21 and Q933) increased from 1% among
bovine isolates to 24% among human clinical isolates. Very strong
correlations were observed between q21 and stx2c and between
Q933 and stx2a. Consequently, like with the Q gene variants, bo-
vine isolates were dominated by isolates carrying only stx2c (86%),
while this frequency was only 37% among clinical isolates. Similar
patterns were reported by recent Norwegian (18) and Japanese
(26) studies. Epidemiological studies have revealed that stx2a is
more strongly associated with clinical isolates and causes more
severe symptoms than stx2c (1, 4, 21, 36). In addition, the effective
dose to inhibit protein synthesis in Vero cells has been reported to
be 100 times lower for stx2a than stx2c, which correlatedwith a 50%
lethality dose for mice 154 times lower than that for stx2a (16).
Intimin (encoded by eae) and its translocated intimin receptor
(encoded by tir) are bacterial proteins that mediate adhesion be-
tween mammalian cells and attaching and effacing (A/E) patho-
gens like STECO157 (20). The results of the tir(A255T) polymor-
phism assay confirm earlier findings of an overrepresentation of
the tir(255T) variant amonghuman clinical isolates of STECO157
isolates and an approximately equal distribution of both variants
among bovine isolates (6, 18). The reason for the specific associ-
ation of human clinical isolates with tir(255T) is unknown. It
might be possible that isolates carrying the tir(255A) allele are
shed for shorter periods of time by cattle and/or survive less well in
manure, soil, water, or food. Another possibility is that STEC
O157 tir(255A) isolates are less virulent for humans than STEC
O157 tir(255T) isolates. It was originally suggested that the central
role of tir in human infection points toward a possible functional
discrimination between both alleles (6). Adherence to epithelial
cells is a major function of the Tir protein; allele polymorphisms
could affect adherence and consequently the association with hu-
man infection (6). The SNP in the tir gene is located near the
amino terminus of the Tir protein, which anchors host cytoskel-
etal components (such as actin) that are needed to form the char-
acteristic A/E lesions on the host cell surface upon bacterial adhe-
sion (32). However, more investigation will be necessary to
delineate the structure-function relationships of these tir(A255T)
polymorphisms and its relationship to the clinical outcome of
infection.
Multivariate statistics revealed that the tir(A255T) single nu-
cleotide polymorphism and the stx2a/stx2c gene variation were the
most differentiating genetic features between bovine, food, and
human isolates from The Netherlands. Bovine isolates compro-
misedmostly stx2c genotypes [tir(255A) stx2c and tir(255T) stx2c)],
while human isolates were dominated by tir(255T) genotypes
Franz et al.
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[tir(255T) stx2a, tir(255T) stx2c, and tir(255T) stx2a stx2c]. The stx2a
gene variation was the most distinctive feature in human isolates
compared to bovine isolates in Japan (26). Other studies showed a
strong association between LSPA6 genotypes and the stx2a/stx2c
genotypes, with a strong bias of stx2a toward LSPA6 LI and of stx2c
to LSPA6 LII (26, 45). The results of the present study are consis-
tent with those studies and showed that LSPA6 LI isolates con-
sisted solely of genotype tir(255T) stx2c, while LSPA6LIIwas dom-
inated by tir(255A) stx2a. As shown previously (26), LSPA6 LI/II
isolates showedmore diversity in tir(A255T) stx2a/stx2c genotypes,
which is in agreement with the suggestion that LSPA6 LI/II is an
intermediate lineage between LI and LII (43).
The results of the present study support the hypothesis that the
STECO157 genotypes which are primarily associatedwith human
disease form a minor subpopulation in the bovine reservoir. This
might argue for more focused regulatory attention on the subset
of STECO157 genotypes dominant among clinical isolates. It is of
interest that the distribution of LSPA6 lineages among bovine and
human isolates is very different in The Netherlands (this study)
than those in North America (38, 45) and Japan (26). To the best
of our knowledge, no other studies have been reported on the
distribution of LSPA6 lineages in European STEC O157 popula-
tions. There are clear geographical differences in STEC O157 dis-
ease incidence, which is generally higher in North America, the
United Kingdom, and Sweden than those inmost continental Eu-
ropean countries (8). These differences might be related to STEC
O157 farmprevalence (28), the environmental load of STECO157
due to super shedders (8), and/or the proportions of human pop-
ulations living in areas with high cattle density (15, 17). In addi-
tion, disease incidence might also be related to the differences in
STEC O157 genetic population structures. The higher disease in-
cidence inNorth America compared to TheNetherlandsmight be
(partly) explained by the difference in LSPA6 lineage I frequency,
which is much higher in North America (38, 43, 45). LSPA6 lin-
eage I is highly correlated with the presence of the more virulent
gene variants like stx2a and tir(255T) andmay therefore result in a
higher disease rate. Indeed, LSPA6 LI isolates showed higher levels
of epithelial adherence and Shiga toxin production than LI and
LI/II strains (30, 44).
Another explanation for the geographic differences in disease
incidence might be that humans are primarily exposed to STEC
O157 by other pathways in different geographic regions (direct
contact with animals and/or feces, environmental transmission,
and food transmission) and that isolates of different LSPA6 lin-
eages differ in their capacity to be transmitted by these routes.
Although a significant longer survival in manure-amended soil of
human STECO157 isolates compared to animal isolates was dem-
onstrated previously, no relationship could be identified between
the virulence profile and survival and between the LSPA6 and
survival (11). Likewise, no differences with respect to survival in
manure were observed between LSPA6 lineage I and II isolates
(31). The underlying reason for the variety in population structure
in different geographic regions with respect to LSPA6 lineage is
still unclear but might be related to specific selection pressures
encountered in the various types of dairy and veal production
systems and their surrounding environments. Future research is
required to reveal the mechanisms responsible for the shaping of
STEC O157 populations and the relationship to differences in
disease incidence in different geographic regions. This can ulti-
mately be used for the development of intervention strategies.
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